GS

Galaxy Surfactants Ltd

Q4 FY25Chemicals & Petrochemicals

Galaxy Surfactants Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹2,333
Market cap₹7.1K Cr
P/E25.6
Updated23 Aug 2026
Read4 min read

The short version

Galaxy Surfactants aims for a 20%+ EBITDA CAGR over the next five years, indicating strong earnings growth. Galaxy Surfactants targets roughly 20% EBITDA CAGR over the next five years, aiming to nearly 2.5x EBITDA growth.

From Galaxy Surfactants Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Galaxy Surfactants aims for a 20%+ EBITDA CAGR over the next five years, indicating strong earnings growth.
  • Volume currently at 2.5 lakh tons; future volume targets not explicitly specified but expected to scale significantly with new products and market expansion.
  • Growth driven by entry into beauty and wellness segments with higher-margin specialty products like modern sun care, derma ingredients, anti-aging actives.
  • Focus on premiumization and penetration in developed markets (Americas and Europe) alongside defending and growing the Indian and AMET (Africa-Middle East-Turkey) markets.
  • Organic growth capital allocation of 50%-60% of operating cash flows to fuel expansion.
  • Innovation pipeline of 20+ new products staged over five years.

2 more points from Galaxy Surfactants Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Galaxy Surfactants Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Galaxy plans to invest 50% to 60% of its incremental operating cash flows into organic growth over the next five years, focusing on beauty and wellness segments.
  • Significant capital will be required to support this growth, as indicated by K. Natarajan and CFO Abhijit Damle.
  • Capital allocation will be balanced across dividends (15%), organic growth (50-60%), and inorganic opportunities like strategic alliances and acquisitions.
  • The company aims to leverage inorganic growth especially through acquisitions, as seen with TRI-K USA acquired in 2009, which now contributes over 20% to earnings.

2 more points from Galaxy Surfactants Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 2
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Galaxy Surfactants Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The document on pages around 32-33 does not explicitly mention current or expected orderbook or pending orders for Galaxy Surfactants Limited. However, relevant insights related to growth and projections include: - Focus on high-margin specialty products such as leave-on products, sun care actives, derma ingredients, hair growth actives, and anti-aging products through strategic subsidiaries like TRI-K. - Targeting volume growth beyond the current 2.5 lakh tons over the next five years, with scalable expansion in new geographies (Americas and Europe) and product segments (beauty and wellness). - Planning significant organic growth investments, allocating 50%-60% of incremental operating cash flows to support this expansion.

2 more points from Galaxy Surfactants Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Galaxy Surfactants Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹62 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Vidhi Specialty Food Ingredients Ltd (Q4 FY25)

    109.5 Crs, up 40.2% YoY (from Rs. Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q4 FY25 earnings call — and how it ranks against sector…

  • Clean Science & Technology Ltd (Q4 FY25)

    2,500 crores to Rs. Key concall takeaways from Clean Science's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Yasho Industries Ltd (Q4 FY25)

    Exports continue to be a key revenue driver, contributing around 67% of total revenue. Key concall takeaways from Yasho Industries's Q4 FY25 earnings call…

  • Vinati Organics Ltd (Q4 FY25)

    Overall growth supported by strategic capex (~INR360 crores in FY26), innovation, and operational efficiencies. Key concall takeaways from Vinati Organics's Q4…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Galaxy Surfactants Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Galaxy Surfactants Ltd Q4 FY25 results?

Galaxy Surfactants aims for a 20%+ EBITDA CAGR over the next five years, indicating strong earnings growth. Galaxy Surfactants targets roughly 20% EBITDA CAGR over the next five years, aiming to nearly 2.5x EBITDA growth.

What is Galaxy Surfactants Ltd share price analysis?

Galaxy Surfactants Ltd currently shows a neutral. The stock trades at a P/E of 25.6 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.

Is Galaxy Surfactants Ltd planning capital expenditure?

Galaxy plans to invest 50% to 60% of its incremental operating cash flows into organic growth over the next five years, focusing on beauty and wellness segments.

Keep Galaxy Surfactants Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.